Information PortalData Portal

Data Matrix

Tools & Workflows

Documentation

Fibroblast growth factor 2 (Protein)

Description: A protein in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Fibroblast growth factor 2 's neighborhood in the knowledge graph.

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
Loading results...

DISPLAY PER PAGE

Report a bug

Data & Metadata

Tools & Use Cases

@CFDE Workbench 2024

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Data & Metadata

Tools & Use Cases

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2024

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
	N-[3-[(3-O-Sulfo-beta-D-glucopyranosyluronicacid)-(1->3)-(2-acetamido-2-deoxy-alpha-D-galactopyranosyl)-(1->6)-(1-deoxy-D-glucitol-1-yl)amino]phenyl]-DL-alpha-lipoamide disodium Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Fibroblast growth factor 2 Protein (Entity type)	Kd
	(2S,3S,4S,5R,6R)-6-{[(2S,3R,4R,5R,6R)-2-{[(2S,3S,4S,5R,6R)-2-carboxy-6-{[(2R,3R,4R,5R,6R)-2-{[(2R,3R,4R,5S)-6-({3-[5-(1,2-dithiolan-3-yl)pentanamido]phenyl}amino)-2,3,4,5-tetrahydroxyhexyl]oxy}-3-acetamido-5-hydroxy-6-[(sulfooxy)methyl]oxan-4-yl]oxy}-4-hydroxy-5-(sulfooxy)oxan-3-yl]oxy}-3-acetamido-5-hydroxy-6-[(sulfooxy)methyl]oxan-4-yl]oxy}-3,4-dihydroxy-5-(sulfooxy)oxane-2-carboxylic acid Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Fibroblast growth factor 2 Protein (Entity type)	Kd
	tetradecasodium[(2R,3R,4S,5R,6R)-2-[(2R,3R,4S,5R,6R)-6-[(2R,3R,4S,5R,6R)-6-[(2R,3R,4S,5R,6R)-6-[[(4R)-4-[(3S,5S,8R,9S,10S,12S,13R,14S,17R)-12-acetoxy-10,13-dimethyl-3-sulfonatooxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]-4,5-disulfonatooxy-2-(sulfonatooxymethyl)tetrahydropyran-3-yl]oxy-4,5-disulfonatooxy-2-(sulfonatooxymethyl)tetrahydropyran-3-yl]oxy-4,5-disulfonatooxy-2-(sulfonatooxymethyl)tetrahydropyran-3-yl]oxy-3,5-disulfonatooxy-6-(sulfonatooxymethyl)tetrahydropyran-4-yl]sulfate Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Fibroblast growth factor 2 Protein (Entity type)	Kd
	N-[3-[(2-O-Sulfo-beta-D-glucopyranosyluronicacid)-(1->3)-(2-acetamido-2-deoxy-alpha-D-galactopyranosyl)-(1->6)-(1-deoxy-D-glucitol-1-yl)amino]phenyl]-DL-alpha-lipoamide disodium Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Fibroblast growth factor 2 Protein (Entity type)	Kd
	3-{4-(Cholestan-3beta-yl-methyl)-[1,2,3]triazol-1-yl}propyl 2,3,4,6-tetra-O-sulfo-alpha-D-mannopyranosyl-(1->3)-2,4,6-tri-O-sulfo-alpha-D-mannopyranosyl-(1->2)-3,4,6-tri-O-sulfo-alpha-D-mannopyranoside, decasodium salt Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Fibroblast growth factor 2 Protein (Entity type)	Kd
	(2S,3S,4S,5R,6R)-6-{[(2S,3R,4R,5R,6R)-2-{[(2S,3S,4S,5R,6R)-2-carboxy-6-{[(2R,3R,4R,5R,6R)-2-{[(2R,3R,4R,5S)-6-({3-[5-(1,2-dithiolan-3-yl)pentanamido]phenyl}amino)-2,3,4,5-tetrahydroxyhexyl]oxy}-3-acetamido-5-hydroxy-6-[(sulfooxy)methyl]oxan-4-yl]oxy}-4-hydroxy-5-(sulfooxy)oxan-3-yl]oxy}-3-acetamido-5-(sulfooxy)-6-[(sulfooxy)methyl]oxan-4-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Fibroblast growth factor 2 Protein (Entity type)	Kd
	hexadecasodium[(2R,3S,4S,5R,6R)-2-[(2R,3S,4S,5R,6R)-2-[(2R,3S,4S,5R,6R)-2-[(2R,3S,4S,5R,6R)-2-[(2S,3S,4R,5R,6R)-2-[3-[4-[[(3S,5S,8R,9S,10S,13R,14S,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxymethyl]triazol-1-yl]propoxy]-4,5-disulfonatooxy-6-(sulfonatooxymethyl)tetrahydropyran-3-yl]oxy-3,5-disulfonatooxy-6-(sulfonatooxymethyl)tetrahydropyran-4-yl]oxy-3,5-disulfonatooxy-6-(sulfonatooxymethyl)tetrahydropyran-4-yl]oxy-3,5-disulfonatooxy-6-(sulfonatooxymethyl)tetrahydropyran-4-yl]oxy-3,5-disulfonatooxy-6-(sulfonatooxymethyl)tetrahydropyran-4-yl]sulfate Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Fibroblast growth factor 2 Protein (Entity type)	Kd
	3beta-cholestanyl 2,3,4,6-tetra-O-sulfo-alpha-D-glucopyranosyl-(1->4)-2,3,6-tri-O-sulfo-alpha-D-glucopyranosyl-(1->4)-2,3,6-tri-O-sulfo-alpha-D-glucopyranosyl-(1->4)-2,3,6-tri-O-sulfo-beta-D-glucopyranoside, tridecasodium salt Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Fibroblast growth factor 2 Protein (Entity type)	Kd
	Octyl 2,3,4,6-Tetra-O-sulfo-alpha-D-mannopyranosyl-(1->3)-2,4,6-tri-O-sulfo-alpha-D-mannopyranosyl-(1->3)-2,4,6-tri-O-sulfo-alpha-D-mannopyranosyl-(1->2)-3,4,6-tri-O-sulfo-alpha-D-mannopyranoside, Tridecasodium salt Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Fibroblast growth factor 2 Protein (Entity type)	Kd
	3-Stearamidopropyl 2,3,4,6-tetra-O-sulfo-alpha-D-mannopyranosyl-(1->3)-2,4,6-tri-Osulfo-alpha-D-mannopyranosyl-(1->3)-2,4,6-tri-O-sulfo-alpha-D-mannopyranosyl-(1->2)-3,4,6-tri-O-sulfo-alpha-D-mannopyranoside, tridecasodium salt Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Fibroblast growth factor 2 Protein (Entity type)	Kd

N-[3-[(3-O-Sulfo-beta-D-glucopyranosyluronicacid)-(1->3)-(2-acetamido-2-deoxy-alpha-D-galactopyranosyl)-(1->6)-(1-deoxy-D-glucitol-1-yl)amino]phenyl]-DL-alpha-lipoamide disodium
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Fibroblast growth factor 2
Protein (Entity type)
Kd

(2S,3S,4S,5R,6R)-6-{[(2S,3R,4R,5R,6R)-2-{[(2S,3S,4S,5R,6R)-2-carboxy-6-{[(2R,3R,4R,5R,6R)-2-{[(2R,3R,4R,5S)-6-({3-[5-(1,2-dithiolan-3-yl)pentanamido]phenyl}amino)-2,3,4,5-tetrahydroxyhexyl]oxy}-3-acetamido-5-hydroxy-6-[(sulfooxy)methyl]oxan-4-yl]oxy}-4-hydroxy-5-(sulfooxy)oxan-3-yl]oxy}-3-acetamido-5-hydroxy-6-[(sulfooxy)methyl]oxan-4-yl]oxy}-3,4-dihydroxy-5-(sulfooxy)oxane-2-carboxylic acid
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Fibroblast growth factor 2
Protein (Entity type)
Kd

tetradecasodium[(2R,3R,4S,5R,6R)-2-[(2R,3R,4S,5R,6R)-6-[(2R,3R,4S,5R,6R)-6-[(2R,3R,4S,5R,6R)-6-[[(4R)-4-[(3S,5S,8R,9S,10S,12S,13R,14S,17R)-12-acetoxy-10,13-dimethyl-3-sulfonatooxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]-4,5-disulfonatooxy-2-(sulfonatooxymethyl)tetrahydropyran-3-yl]oxy-4,5-disulfonatooxy-2-(sulfonatooxymethyl)tetrahydropyran-3-yl]oxy-4,5-disulfonatooxy-2-(sulfonatooxymethyl)tetrahydropyran-3-yl]oxy-3,5-disulfonatooxy-6-(sulfonatooxymethyl)tetrahydropyran-4-yl]sulfate
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Fibroblast growth factor 2
Protein (Entity type)
Kd

N-[3-[(2-O-Sulfo-beta-D-glucopyranosyluronicacid)-(1->3)-(2-acetamido-2-deoxy-alpha-D-galactopyranosyl)-(1->6)-(1-deoxy-D-glucitol-1-yl)amino]phenyl]-DL-alpha-lipoamide disodium
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Fibroblast growth factor 2
Protein (Entity type)
Kd

3-{4-(Cholestan-3beta-yl-methyl)-[1,2,3]triazol-1-yl}propyl 2,3,4,6-tetra-O-sulfo-alpha-D-mannopyranosyl-(1->3)-2,4,6-tri-O-sulfo-alpha-D-mannopyranosyl-(1->2)-3,4,6-tri-O-sulfo-alpha-D-mannopyranoside, decasodium salt
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Fibroblast growth factor 2
Protein (Entity type)
Kd

(2S,3S,4S,5R,6R)-6-{[(2S,3R,4R,5R,6R)-2-{[(2S,3S,4S,5R,6R)-2-carboxy-6-{[(2R,3R,4R,5R,6R)-2-{[(2R,3R,4R,5S)-6-({3-[5-(1,2-dithiolan-3-yl)pentanamido]phenyl}amino)-2,3,4,5-tetrahydroxyhexyl]oxy}-3-acetamido-5-hydroxy-6-[(sulfooxy)methyl]oxan-4-yl]oxy}-4-hydroxy-5-(sulfooxy)oxan-3-yl]oxy}-3-acetamido-5-(sulfooxy)-6-[(sulfooxy)methyl]oxan-4-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Fibroblast growth factor 2
Protein (Entity type)
Kd

hexadecasodium[(2R,3S,4S,5R,6R)-2-[(2R,3S,4S,5R,6R)-2-[(2R,3S,4S,5R,6R)-2-[(2R,3S,4S,5R,6R)-2-[(2S,3S,4R,5R,6R)-2-[3-[4-[[(3S,5S,8R,9S,10S,13R,14S,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxymethyl]triazol-1-yl]propoxy]-4,5-disulfonatooxy-6-(sulfonatooxymethyl)tetrahydropyran-3-yl]oxy-3,5-disulfonatooxy-6-(sulfonatooxymethyl)tetrahydropyran-4-yl]oxy-3,5-disulfonatooxy-6-(sulfonatooxymethyl)tetrahydropyran-4-yl]oxy-3,5-disulfonatooxy-6-(sulfonatooxymethyl)tetrahydropyran-4-yl]oxy-3,5-disulfonatooxy-6-(sulfonatooxymethyl)tetrahydropyran-4-yl]sulfate
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Fibroblast growth factor 2
Protein (Entity type)
Kd

3beta-cholestanyl 2,3,4,6-tetra-O-sulfo-alpha-D-glucopyranosyl-(1->4)-2,3,6-tri-O-sulfo-alpha-D-glucopyranosyl-(1->4)-2,3,6-tri-O-sulfo-alpha-D-glucopyranosyl-(1->4)-2,3,6-tri-O-sulfo-beta-D-glucopyranoside, tridecasodium salt
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Fibroblast growth factor 2
Protein (Entity type)
Kd

Octyl 2,3,4,6-Tetra-O-sulfo-alpha-D-mannopyranosyl-(1->3)-2,4,6-tri-O-sulfo-alpha-D-mannopyranosyl-(1->3)-2,4,6-tri-O-sulfo-alpha-D-mannopyranosyl-(1->2)-3,4,6-tri-O-sulfo-alpha-D-mannopyranoside, Tridecasodium salt
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Fibroblast growth factor 2
Protein (Entity type)
Kd

3-Stearamidopropyl 2,3,4,6-tetra-O-sulfo-alpha-D-mannopyranosyl-(1->3)-2,4,6-tri-Osulfo-alpha-D-mannopyranosyl-(1->3)-2,4,6-tri-O-sulfo-alpha-D-mannopyranosyl-(1->2)-3,4,6-tri-O-sulfo-alpha-D-mannopyranoside, tridecasodium salt
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Fibroblast growth factor 2
Protein (Entity type)
Kd

DISPLAY PER PAGE